Biotech Archives - Page 669 of 795

2 minute read

Rockley Photonics To Expand Free-Living Human Study Of Its Bioptx Biosensing Band Across Broader Group Of Participants

October 6, 4:26 PM

Expansion marks progress in the development of wearable biosensing platform to monitor multiple key biomarkers in real-time Study expected to demonstrate the capability of Rockley's Bioptx™ biosensing band

RKLY

2 minute read

Lyell Immunopharma Announces FDA Clearance Of Its IND For LYL845, A TIL Product Candidate Enhanced With Its Novel Epigenetic Reprogramming Technology For Solid Tumors

By Benzinga Newsdesk

October 6, 4:07 PM

Autologous TIL therapy enhanced with Lyell's Epi-R™ reprogramming technology designed to create polyclonal T cell populations with properties of durable stemness and improved function Phase 1 trial

LYEL

1 minute read

Verve’s Stock Price Could Continue To Rise Through Clinical Progress – Despite Worries About “DeeperPocketed” Competition

By Vandana Singh

October 6, 3:49 PM

Credit Suisse has initiated coverage on Verve Therapeutics Inc (NASDAQ:VERV) with a Neutral rating and a $48 target price. Its lead assets…

MRK

1 minute read

Cyclerion Shares Fall After Reprioritized Pipeline, Workforce Reduction

By Vandana Singh

October 6, 12:46 PM

Cyclerion Therapeutics Inc (NASDAQ:CYCN) is reprioritizing development programs and focusing resources and capabilities on candidates for mitochondrial diseases. The company has…

CYCN

1 minute read

Surrozen Inks Strategic Partnership With Boehringer Ingelheim For Retinal Disease Candidate

By Vandana Singh

October 6, 12:33 PM

Surrozen Inc (NASDAQ:SRZN) entered into a collaboration and license agreement with Boehringer Ingelheim to research and develop SZN-413 for retinal diseases. SZN-413 is…

SRZN

1 minute read

Aldeyra’s ADX-2191 Aces Late-Stage Study In Rare Vision Disorder

By Vandana Singh

October 6, 12:23 PM

Aldeyra Therapeutics Inc (NASDAQ:ALDX) achieved the primary endpoint in Part 1 of the Phase 3 GUARD Trial of ADX-2191 (methotrexate injection,…

ALDX

1 minute read

CytoSorbents Secures US Govt Contract For Customized Filter Freeze-Dried Universal Plasma

By Vandana Singh

October 6, 11:12 AM

The U.S. Army Medical Research Acquisition Activity has awarded CytoSorbents Corp (NASDAQ:CTSO) a three-year Phase 3 contract valued at $4.3 million for…

CTSO

1 minute read

Eli Lilly’s Obesity Drug, Tirzepatide, Fast Tracked In US; Rolling Submission To Start This Year

By Vandana Singh

October 6, 11:06 AM

The FDA has granted Fast Track designation for Eli Lilly And Co’s (NYSE: LLY) tirzepatide for adults with obesity or overweight with weight-related…

LLY

3 minute read

FDA
News

Desktop Health Receives FDA Clearance For SmileGuard Resin For Durable And Comfortable Orthodontic And Dental Appliances

By Benzinga Newsdesk

October 6, 8:43 AM

Dentists and labs can use proprietary SmileGuard resin to 3D print bite splints, night guards, and mouth guards in the office in as little as one hour, allowing same-day delivery Compared to other 3D printed

1 minute read

Mustang Bio Announces First Patient Treated In Multicenter Phase 1/2 Clinical Trial Of MB-106

By Bill Haddad

October 6, 8:33 AM

Mustang Bio, Inc.

FBIO